Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...
The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...
Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...
HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...
RFK Jr. says TrumpRX will launch "probably in the next 10 days." What we know about how buying medicine, getting discounts on ...
CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results